PMID- 30081071 OWN - NLM STAT- MEDLINE DCOM- 20190919 LR - 20190919 IS - 1878-5921 (Electronic) IS - 0895-4356 (Linking) VI - 104 DP - 2018 Dec TI - Clinical trials on drug-drug interactions registered in ClinicalTrials.gov reported incongruent safety data in published articles: an observational study. PG - 35-45 LID - S0895-4356(18)30213-0 [pii] LID - 10.1016/j.jclinepi.2018.07.017 [doi] AB - OBJECTIVE: To assess safety data of trials on drug-drug interactions (DDIs) reported in ClinicalTrials.gov and published in journal articles, since DDIs are a growing concern. STUDY DESIGN AND SETTING: In an observational study of clinical trials retrieved by the search term "drug-drug interaction(s)," we collected the information on registration and on adverse events (AEs) from ClinicalTrials.gov and corresponding publications. Trials were included if they primarily investigated DDIs, had a National Clinical Trial identifier, and were closed and completed by October 16, 2015. Publication data were extracted until March 2017. RESULTS: Among 1,110 eligible trials, most were in phase 1 (76.8%), industry-funded (68.8%), and started before registration (56.9%). Results were not reported in the registry for 86.8% and not published for 68.1% trials. Published AE data were completely identical to the data submitted to ClinicalTrials.gov for only 15.6% trials. Among 64 trials with results reported both in ClinicalTrials.gov and publications, 34.4% published concordant number for other AEs. CONCLUSION: Discrepancies that emerge from incomplete or changed reporting of AEs in publications emphasize the need to amend and enforce regulatory requirements for timely and complete submission of results, clearer AE reporting for trials focusing on DDIs, and regular assessment of the congruence of AE data submitted to ClinicalTrials.gov and scientific journals during the publication process. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Juric, Diana AU - Juric D AD - Department of Pharmacology, University of Split School of Medicine, Split, Croatia. Electronic address: diana.juric@mefst.hr. FAU - Pranic, Shelly AU - Pranic S AD - Department of Public Health, University of Split School of Medicine, Split, Croatia; Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia. FAU - Tokalic, Ruzica AU - Tokalic R AD - Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia. FAU - Milat, Ana Marija AU - Milat AM AD - Department of Pharmacology, University of Split School of Medicine, Split, Croatia. FAU - Mudnic, Ivana AU - Mudnic I AD - Department of Pharmacology, University of Split School of Medicine, Split, Croatia. FAU - Pavlicevic, Ivancica AU - Pavlicevic I AD - Department of Family Medicine, University of Split School of Medicine, Split, Croatia. FAU - Marusic, Ana AU - Marusic A AD - Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20180803 PL - United States TA - J Clin Epidemiol JT - Journal of clinical epidemiology JID - 8801383 SB - IM MH - Adverse Drug Reaction Reporting Systems/*statistics & numerical data MH - Clinical Trials as Topic MH - *Drug Interactions MH - Humans MH - *Publications MH - Registries MH - Research Design OTO - NOTNLM OT - Adverse events OT - Bias OT - Clinical trials on drug-drug interaction as topic OT - Databases OT - Drug interaction OT - Reporting EDAT- 2018/08/07 06:00 MHDA- 2019/09/20 06:00 CRDT- 2018/08/07 06:00 PHST- 2018/03/12 00:00 [received] PHST- 2018/07/26 00:00 [revised] PHST- 2018/07/31 00:00 [accepted] PHST- 2018/08/07 06:00 [pubmed] PHST- 2019/09/20 06:00 [medline] PHST- 2018/08/07 06:00 [entrez] AID - S0895-4356(18)30213-0 [pii] AID - 10.1016/j.jclinepi.2018.07.017 [doi] PST - ppublish SO - J Clin Epidemiol. 2018 Dec;104:35-45. doi: 10.1016/j.jclinepi.2018.07.017. Epub 2018 Aug 3.